
|
Report Date : |
29.03.2007 |
IDENTIFICATION
DETAILS
|
Name : |
BLUE CIRCLE CORPORATION |
|
|
|
|
Registered Office : |
34, Empire Bldg., 1st Floor, 146 Dr. D N Road, Fort, Mumbai
400001. Maharashtra. |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
1991 |
|
|
|
|
IEC No.: |
0391007165 |
|
|
|
|
Legal Form : |
A Sole Proprietory Concern |
|
|
|
|
Line of Business : |
Exporter of fine Chemicals and
Intermediates. |
RATING &
COMMENTS
|
MIRAs Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
|
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well-established concern having satisfactory track. Trade
relations are fair. Financed position is satisfactory. Payments are usually
correct and as per commitments. The concern can be considered normal for business dealings at usual
trade terms and conditions. |
LOCATIONS
|
Registered Office : |
34, Empire Bldg., 1st Floor, 146, Dr. D N Road Fort, Mumbai
400001. Maharashtra. India. |
|
Tel. No.: |
91-22-22075307/22071691 |
|
Mobile No.: |
91-9820002315 |
|
Fax No.: |
91-22-22070294 |
|
E-Mail : |
|
|
Website : |
http://www.bluecirclespeciality.com |
|
Area : |
300 Sq.Ft. |
|
Location : |
Rented |
SOLE PROPRIETOR
|
Name : |
Mr. Akshay B. Arora |
|
Designation : |
Sole Proprietor |
|
Address : |
Plot No. 126, J Lane Sector-8, Vashi, Navi Mumbai. |
|
Date of Birth/Age : |
44 Yrs. |
|
Qualification : |
M.Sc. |
|
Experience : |
20 Yrs. |
BUSINESS DETAILS
|
Line of Business : |
Exporter |
|
|
|
|
Products : |
Pharma Intermediates X Ray Contrast Media Intermediates Custom Synthesis Manufactured by Sister Concerns |
|
|
|
|
Exports : |
|
|
Products : |
Media intermediates |
|
Countries : |
Italy Bracco Imaging Sweden Cambrex Group Israel Teva Pharmacuticals Limited |
|
|
|
|
Terms : |
|
|
Selling : |
Credit (60 days) |
|
|
|
|
Purchasing : |
Credit (30 days) |
GENERAL
INFORMATION
|
Customers : |
End Users |
|
|
|
|
No. of Employees : |
4 |
|
|
|
|
Bankers : |
Citi Bank N. A. Corporate Branch Fort, Mumbai ( Bill discounting facility
Rs. 8..000 Millions) Canara Bank Turbhe Branch, Vashi, Navi Mumbai. (Overdraft facility Rs. 3.500 Millions) |
|
Banking
Relations : |
--- |
|
|
|
|
Associates/Subsidiaries : |
Jet Chemicals Private Limited (JCPL) 3/2, Mile Stone, Village Varap, Kalyan Murbad Road, Shahad 421103.
Dist Thane. India Tel. No. - 91-251-2280283 Fax. No. 91-251-2280567 Blue Circle Speciality Chemicals Private Limited (BCSCPL) W- 116, MIDC Phase II, Dombivli 421203. Dist Thane India. Tel NO. 91-251-2870823 Fax No. 91-251-2871941 Blue Circle Organics Private Limited (BCOPL) Plot No. C 4, B 12, E 2, MIDC Ambernath . Tel No. 91-251-2610736 Fax No. 91-251-2610736 |
FINANCIAL DATA
[all figures are in Rupees Millions]
CAPITAL STRUCTURE
|
Capital Investment : |
|
|
Owned : |
Rs.120.000 Millions |
|
Borrowed : |
Rs. 11.500 Millions |
|
Total : |
Rs.131.500 Millions |
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
|
31.03.2007 (Projected) |
|
SHAREHOLDERS FUNDS |
|
|
|
|
1] Share Capital |
|
|
28.309 |
|
2] Share Application Money |
|
|
0.000 |
|
3] Reserves & Surplus |
|
|
0.000 |
|
4] (Accumulated Losses) |
|
|
0.000 |
|
NETWORTH |
|
|
28.309 |
|
LOAN FUNDS |
|
|
|
|
1] Secured Loans |
|
|
3.217 |
|
2] Unsecured Loans |
|
|
0.000 |
|
TOTAL BORROWING |
|
|
3.217 |
|
DEFERRED TAX LIABILITIES |
|
|
|
|
NET PROFIT |
|
|
2.204 |
|
TOTAL |
|
|
33.730 |
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
|
1.950 |
|
Capital work-in-progress |
|
|
21.182 |
|
|
|
|
|
|
INVESTMENT |
|
|
10.598 |
|
DEFERREX TAX ASSETS |
|
|
0.000 |
|
|
|
|
|
|
TOTAL |
|
|
33.730 |
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
|
31.03.2007 (Projected) |
|
|
Sales Turnover |
|
|
75.871 |
|
|
Other Income |
|
|
7.111 |
|
|
Total Income |
|
|
82.982 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
|
2.249 |
|
|
Provision for Taxation |
|
|
0.000 |
|
|
Profit/(Loss) After Tax |
|
|
2.249 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Direct Expenses |
|
|
9.446 |
|
|
Indirect Expenses |
|
|
5.496 |
|
Total Expenditure |
|
|
14.942 |
|
KEY RATIOS
|
PARTICULARS |
|
|
|
31.03.2007 (Projected) |
|
PAT / Total Income |
(%) |
|
|
2.71 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
|
|
2.96 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
|
|
115.33 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
|
|
0.07 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
|
0.11 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
|
--- |
LOCAL AGENCY
FURTHER INFORMATION
Trade References :
1) U.S. Vitamins limited
2) Nicholas Piramal Private Limited
3) Zandu Chemicals Limited
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Intl
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a companys management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.59 |
|
UK Pound |
1 |
Rs.85.53 |
|
Euro |
1 |
Rs.58.14 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
54 |
This score serves as a reference to assess SCs credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|